Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 404 followers
Latest posts
Last updated about 16 hours ago
Accelerating clinical trials with precision logistics
about 16 hours ago
Learn how Marken’s Laboratory Advantage improves speed, visibility and compliance to keep...
FDA snubs AbbVie's prospective Botox heir amid series of manufacturing-related CRLs
about 20 hours ago
The FDA rejected two new products from AbbVie and Grace Therapeutics, citing...
Sanofi gains long-awaited win for tolebrutinib as EU regulator endorses MS drug for approval
about 20 hours ago
After a series of setbacks for Sanofi’s tolebrutinib, the French company has...
Daiichi pushes back annual report, citing reviews amid ‘rapidly changing business conditions’
about 21 hours ago
Daiichi Sankyo has postponed its annual report by two weeks, citing additional...
Travere’s launchpad positions Filspari for fast rise toward blockbuster sales: analyst
about 21 hours ago
An established sales force and payer authorization criteria will fuel a fast...
Genentech wants ‘All Eyes on DME’ as it taps Damon Wayans for humor-laced campaign
about 22 hours ago
Roche’s Genentech unit is launching a new multimedia campaign aimed at sharing...
Can Trump’s deal with the UK become a model for similar drug price agreements?
about 22 hours ago
Trump’s deal with the UK links tariffs to drug pricing. On this...
Pfizer's cost-cutting push reaches Ireland again as it plans manufacturing layoffs
about 23 hours ago
During Pfizer's right-sizing push after the COVID-19 pandemic, the company's multibillion-dollar cost-cutting...
Pfizer drafts Fernando Mendoza as new face of its ‘game of inches’ cancer campaign
about 23 hours ago
Pfizer is kicking off the next stage of its cancer awareness program...
Fierce Pharma Asia—Merck’s PD-1xVEGF data; Zai Lab’s global view; Kailera’s record IPO
about 23 hours ago
Merck & Co. unveiled the much-anticipated first look at its PD-1xVEGF bispecific...
Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs
about 24 hours ago
Avalyn Pharma is hoping to rake in around $181.8 million from an...
Patients less confident than ever about health choices: survey
1 day ago
Patients’ confidence in their ability to find answers about health questions and...